| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |